These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3120383)

  • 21. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A; Burman W; Benator D; Khan A; Bozeman L
    Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 23. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Am Rev Respir Dis; 1972 Jul; 106(1):1-22. PubMed ID: 4624794
    [No Abstract]   [Full Text] [Related]  

  • 24. Difficulties in the diagnosis and treatment of drug-resistant tuberculosis and tuberculous empyema.
    Glisson J; Mehta JB
    J Tenn Med Assoc; 1992 Sep; 85(9):419-22. PubMed ID: 1405623
    [No Abstract]   [Full Text] [Related]  

  • 25. [Initial resistance to streptomycin, isoniazid, thiacetazone, rifampicin and ethambutol in bacilliferous tuberculosis in Maniema, Zaire].
    De Caluwé P; Everaerts MC; Dufour B; wa Tshalumba M
    Ann Soc Belg Med Trop; 1989 Jun; 69(2):143-7. PubMed ID: 2508582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis].
    Khomenko AG; Chesak OI; Biazov TA; Chaikina TN
    Probl Tuberk; 1972; 50(10):28-32. PubMed ID: 4633557
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
    Korotaev GA; Kozulitsyna TI; Tret'iakova EA; Mamed'iarova FA
    Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental tuberculosis in mice, a model for the study of antitubercular chemotherapy].
    Rist N
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):295-6. PubMed ID: 5004388
    [No Abstract]   [Full Text] [Related]  

  • 30. Sensitivity tests.
    Tubercle; 1970 Mar; 51(1):103-5. PubMed ID: 4992975
    [No Abstract]   [Full Text] [Related]  

  • 31. The chemotherapy of pulmonary tuberculosis: a review.
    Fox W
    Chest; 1979 Dec; 76(6 Suppl):785-96. PubMed ID: 92393
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Clin Chest Med; 1980 May; 1(2):243-52. PubMed ID: 6794977
    [No Abstract]   [Full Text] [Related]  

  • 33. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. X. September 1970 to September 1973.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1974 Jul; 110(1):95-8. PubMed ID: 4209360
    [No Abstract]   [Full Text] [Related]  

  • 34. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346
    [No Abstract]   [Full Text] [Related]  

  • 35. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
    Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
    Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of pulmonary tuberculosis.
    Johnston RF; Hopewell PC
    Ann Intern Med; 1969 Feb; 70(2):359-67. PubMed ID: 4974415
    [No Abstract]   [Full Text] [Related]  

  • 37. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
    Ianovskaia OM; Poliakova AN; Samuliak ID; Vasilik GV
    Probl Tuberk; 1975; (11):69-71. PubMed ID: 815904
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM; Shrentsel' OA
    Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
    Shilakadze EM; Margadze GKh; Zautashvili MG
    Probl Tuberk; 1975; (3):79. PubMed ID: 124432
    [No Abstract]   [Full Text] [Related]  

  • 40. The action of antituberculosis drugs in short-course chemotherapy.
    Mitchison DA
    Tubercle; 1985 Sep; 66(3):219-25. PubMed ID: 3931319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.